John P. Bilezikian

905 total papers · 76.1k total citations
621 papers, 43.2k citations indexed

About

John P. Bilezikian is a scholar working on Orthopedics and Sports Medicine, Oncology and Nephrology. According to data from OpenAlex, John P. Bilezikian has authored 621 papers receiving a total of 43.2k indexed citations (citations by other indexed papers that have themselves been cited), including 278 papers in Orthopedics and Sports Medicine, 262 papers in Oncology and 245 papers in Nephrology. Recurrent topics in John P. Bilezikian's work include Bone health and osteoporosis research (267 papers), Bone health and treatments (246 papers) and Parathyroid Disorders and Treatments (244 papers). John P. Bilezikian is often cited by papers focused on Bone health and osteoporosis research (267 papers), Bone health and treatments (246 papers) and Parathyroid Disorders and Treatments (244 papers). John P. Bilezikian collaborates with scholars based in United States, Italy and Canada. John P. Bilezikian's co-authors include Shonni J. Silverberg, Mishaela R. Rubin, Andrea Giustina, John T. Potts, Elizabeth Shane, Aliya Khan, Barbara C. Silva, Natalie E. Cusano, Ernesto Canalis and Donald J. McMahon and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

John P. Bilezikian

614 papers receiving 41.6k citations

Hit Papers

Guidelines for the Manage... 1999 2026 2008 2017 2009 2003 2012 2007 2014 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop
    2009 1.1k citations John P. Bilezikian, Aliya Khan et al. The Journal of Clinical Endocrinology & Metabolism profile →
  2. The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis
    2003 866 citations Dennis M. Black, Susan L. Greenspan et al. New England Journal of Medicine profile →
  3. Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
    2012 837 citations Rajesh V. Thakker, Paul Newey et al. The Journal of Clinical Endocrinology & Metabolism profile →
  4. Glucocorticoid-induced osteoporosis: pathophysiology and therapy
    2007 810 citations Ernesto Canalis, Gherardo Mazziotti et al. Osteoporosis International profile →
  5. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop
    2014 794 citations John P. Bilezikian, Maria Luisa Brandi et al. The Journal of Clinical Endocrinology & Metabolism profile →
  6. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
    2018 707 citations Roger Bouillon, Claudio Marcocci et al. Endocrine Reviews profile →
  7. Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image
    2014 610 citations Barbara C. Silva, William D. Leslie et al. Journal of Bone and Mineral Research profile →
  8. A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery
    1999 545 citations Shonni J. Silverberg, Elizabeth Shane et al. New England Journal of Medicine profile →
  9. Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century
    2002 526 citations John P. Bilezikian, John T. Potts et al. The Journal of Clinical Endocrinology & Metabolism profile →
  10. Mechanisms of Anabolic Therapies for Osteoporosis
    2007 511 citations Ernesto Canalis, Andrea Giustina et al. New England Journal of Medicine profile →
  11. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions
    2008 440 citations E. Michael Lewiecki, Catherine M. Gordon et al. Bone profile →
  12. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
    2014 435 citations Ethel S. Siris, Robert A. Adler et al. Osteoporosis International profile →
  13. Executive Summary of the 2013 International Society for Clinical Densitometry Position Development Conference on Bone Densitometry
    2013 433 citations John T. Schousboe, John Shepherd et al. Journal of Clinical Densitometry profile →
  14. Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
    2012 394 citations Nelson B. Watts, Robert A. Adler et al. The Journal of Clinical Endocrinology & Metabolism profile →
  15. Interpretation and use of FRAX in clinical practice
    2011 380 citations John А. Kanis, Didier Hans et al. Osteoporosis International profile →
  16. Parathyroid hormone: anabolic and catabolic actions on the skeleton
    2015 372 citations Barbara C. Silva, John P. Bilezikian Current Opinion in Pharmacology profile →
  17. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
    2015 337 citations Nelson B. Watts, John P. Bilezikian et al. The Journal of Clinical Endocrinology & Metabolism profile →
  18. Hyperparathyroidism
    2017 321 citations John P. Bilezikian, Leonardo Bandeira et al. The Lancet profile →
  19. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D
    2018 216 citations Christopher T. Sempos, Annemieke C. Heijboer et al. British Journal of Clinical Pharmacology profile →
  20. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
    2020 192 citations John P. Bilezikian, Aliya Khan et al. Journal of Bone and Mineral Research profile →
  21. Consensus statement from 2nd International Conference on Controversies in Vitamin D
    2020 190 citations Andrea Giustina, Robert A. Adler et al. Reviews in Endocrine and Metabolic Disorders profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John P. Bilezikian 17.0k 15.7k 15.4k 10.6k 10.6k 621 43.2k
Maria Luisa Brandi 8.7k 0.5× 5.5k 0.4× 8.8k 0.6× 7.8k 0.7× 6.3k 0.6× 766 29.4k
Richard Eastell 26.5k 1.6× 3.4k 0.2× 17.5k 1.1× 11.7k 1.1× 9.8k 0.9× 631 42.3k
Sundeep Khosla 21.5k 1.3× 2.7k 0.2× 14.9k 1.0× 21.2k 2.0× 7.7k 0.7× 508 51.5k
B. Lawrence Riggs 29.3k 1.7× 2.9k 0.2× 15.1k 1.0× 18.7k 1.8× 9.9k 0.9× 390 55.4k
Claus Christiansen 20.3k 1.2× 2.3k 0.1× 12.8k 0.8× 11.3k 1.1× 6.4k 0.6× 681 45.6k
Robert R. Recker 21.9k 1.3× 2.6k 0.2× 12.9k 0.8× 14.5k 1.4× 4.8k 0.5× 464 39.4k
Pierre D. Delmas 28.0k 1.6× 2.1k 0.1× 16.7k 1.1× 12.5k 1.2× 8.1k 0.8× 403 45.0k
John А. Kanis 39.1k 2.3× 2.4k 0.2× 18.4k 1.2× 14.5k 1.4× 21.7k 2.0× 593 60.3k
Ian R. Reid 17.2k 1.0× 2.6k 0.2× 11.0k 0.7× 8.4k 0.8× 4.2k 0.4× 490 31.3k
Leif Mosekilde 9.2k 0.5× 4.5k 0.3× 5.4k 0.4× 4.7k 0.4× 4.8k 0.5× 383 22.9k

Countries citing papers authored by John P. Bilezikian

Since Specialization
Citations

This map shows the geographic impact of John P. Bilezikian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Bilezikian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Bilezikian more than expected).

Fields of papers citing papers by John P. Bilezikian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Bilezikian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Bilezikian. The network helps show where John P. Bilezikian may publish in the future.

Co-authorship network of co-authors of John P. Bilezikian

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Bilezikian. A scholar is included among the top collaborators of John P. Bilezikian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Bilezikian. John P. Bilezikian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rena R. Wing Breakdown of academic impact, for papers by Gary H. Lyman Breakdown of academic impact, for papers by Luigi Cavallo Breakdown of academic impact, for papers by San Ping Jiang Breakdown of academic impact, for papers by Adrian Bejan Breakdown of academic impact, for papers by Andrew J.S. Coats Breakdown of academic impact, for papers by Ping Sheng Breakdown of academic impact, for papers by Thoralf M. Sundt
Rankless by CCL
2026